Systematically comparing epidemiological and clinical features of MAFLD and NAFLD by meta‐analysis: Focusing on the non‐overlap groups

Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease

(2021) Shang-Chin Huang et al.   Gut and Liver

Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?

(2021) Gabriel Tayguara Silveira Guerreiro et al.   Hepatology International

Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population

(2021) Stefano Ciardullo et al.   LIVER INTERNATIONAL

Outcomes of NAFLD and MAFLD: Results from a community-based, prospective cohort study

(2021) Madunil Anuk Niriella et al.   PLoS One

Metabolic dysfunction associated fatty liver disease improves detection of high liver stiffness: The rotterdam study

(2021) Laurens van Kleef et al.   HEPATOLOGY

MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: Generalized estimating equation approach

(2021) Tsubasa Tsutsumi et al.   HEPATOLOGY RESEARCH

Non-Obese MAFLD Is Associated with Colorectal Adenoma in Health Check Examinees: A Multicenter Retrospective Study

(2021) Shuhei Fukunaga et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Metabolic dysfunction-associated fatty liver disease and mortality among Chinese adults: a prospective cohort study

(2021) Xiaomo Wang et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Association of MAFLD with diabetes, chronic kidney disease, and cardiovascular disease: a 4.6-year cohort study in China

(2021) Yebei Liang et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States

(2021) Donghee Kim et al.   JOURNAL OF HEPATOLOGY

The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases

(2021) Hideki Fujii et al.   Scientific Reports

Comparing the Diagnostic Criteria of MAFLD and NAFLD in the Chinese Population: A Population-based Prospective Cohort Study

(2021) Cheng Yu et al.   Journal of Clinical and Translational Hepatology

Differential Clinical Characteristics and Mortality Outcomes in Persons With NAFLD and/or MAFLD

(2021) Vy H. Nguyen et al.   Clinical Gastroenterology and Hepatology

MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease

(2020) Mohammed Eslam et al.   GASTROENTEROLOGY

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

(2020) Mohammed Eslam et al.   JOURNAL OF HEPATOLOGY

Comparison of MAFLD and NAFLD diagnostic criteria in real world

(2020) Su Lin et al.   LIVER INTERNATIONAL

MAFLD identifies patients with significant hepatic fibrosis better than NAFLD

(2020) Sakura Yamamura et al.   LIVER INTERNATIONAL

Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study

(2020) Hokyou Lee et al.   Clinical Gastroenterology and Hepatology

Clinical utility of the MAFLD definition

(2020) Kenneth I. Zheng et al.   JOURNAL OF HEPATOLOGY

MAFLD and risk of CKD

(2020) Dan-Qin Sun et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Impact of the New Definition of Metabolic Associated Fatty Liver Disease on the Epidemiology of the Disease

(2020) Vincent Wai-Sun Wong et al.   Clinical Gastroenterology and Hepatology

Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study

(2019) Francesco Baratta et al.   Clinical Gastroenterology and Hepatology

Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

(2018) Chris Estes et al.   JOURNAL OF HEPATOLOGY

Recommendations for Management and Treatment of Nonalcoholic Steatohepatitis

(2018) Vlad Ratziu et al.   TRANSPLANTATION

Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases

(2017) Leon A Adams et al.   GUT

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

(2017) Zobair Younossi et al.   Nature Reviews Gastroenterology & Hepatology

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

Inactivation ofTm6sf2, a Gene Defective in Fatty Liver Disease, Impairs Lipidation but Not Secretion of Very Low Density Lipoproteins

(2016) Eriks Smagris et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations

(2015) Brian Hutton et al.   ANNALS OF INTERNAL MEDICINE

Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome

(2014) Hannele Yki-Järvinen   Lancet Diabetes & Endocrinology

Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis

(2011) Ruben Hernaez et al.   HEPATOLOGY

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

(2008) Stefano Romeo et al.   NATURE GENETICS